QA/AI & ML Compliance Services

Where Quality Governance Meets Digital Compliance

Person typing on laptop with overlays for AI and ethics

The rapid evolution of artificial intelligence, automation, and digital systems is reshaping regulated industries. ProPharma's QA/AI & ML Compliance Services bridge the gap between innovation and compliance, providing strategic, technical, and regulatory expertise to help you confidently adopt AI and digital technologies, while maintaining GxP integrity and global regulatory alignment.

Empowering Life Science Organizations to Govern Artificial Intelligence (AI) System Compliance Responsibly in the Digital Era.

Globally integrate compliance with AI, digital technologies, and data-driven systems with confidence, Ensuring compliance, validation, and governance are built into every step of the technology-enabled journey.

Connection

AI Strategy Development, Readiness & Implementation

Adverse event intake icon

AI Validation, GxP Compliance & Governance

Signal management icon

Data Integrity (DI) Compliance Assessments

Pharmacovigilance

Cybersecurity Readiness Audits (GxP Focused)

Business professionals collaborating

ProPharma is Your Partner for AI-Driven Quality and Compliance Excellence, delivering:

Regulatory Expertise: Experience with FDA, EMA, MHRA, PMDA, and Health Canada expectations.

Proven AI & MReadiness Frameworks: Designed for scalable, compliant adoption.

Cross-Functional Expertise: Blending QA, data science, IT, and regulatory insights.

End-to-End Support: From strategy and validation to governance and audit readiness.

Comprehensive Support Across Your AI & ML Compliance Journey

Quality & Compliance Interconnected services are designed to ensure compliant, validated, and high-performing digital ecosystems

AI Strategy Development, Readiness & Implementation

Strengthening the foundation for AI success through structured readiness, governance, and implementation support that aligns with business and regulatory objectives.

  • Supporting clients on AI adoption and process enhancement
  • Enabling faster, smarter decision-making through integrated data and automation
  • Building internal AI capability and readiness
  • Proactively managing compliance and regulatory expectations
  • AI Readiness & Maturity Assessment
  • Digital Blueprint Development & Implementation
  • High-Impact AI Opportunity Identification
  • AI Partnership & Vendor Selection Support
  • AI Implementation Support (Business Process Optimization, OCM)
  • Governance & Performance Monitoring Frameworks
  • AI Compliance & Validation Plan

AI Validation, GxP Compliance & Governance

Ensure your AI/ML tools and algorithms meet stringent GxP, EMA, and FDA regulatory expectations through structured validation and compliance governance.

  • Validation of AI/ML applications in GxP processes (Manufacturing, QC, Clinical, etc.)
  • Assessment of algorithm training data integrity, bias, and traceability
  • Regulatory alignment verification for AI/ML systems in development and manufacturing
  • Validation Protocols & Reports
  • Algorithm Risk Assessments
  • AI/ML Lifecycle SOPs
  • Compliance Roadmaps for AI Use Cases

Data Integrity (DI) Compliance Assessments

Safeguard data trustworthiness and compliance during your digital transformation. Our DI experts assess, align compliance, and enhance your data integrity practices across systems and operations.

  • End-to-end DI audits for digital systems and applications
  • Evaluation of ALCOA+ principles, system controls, audit trails, backup/recovery
  • Map gaps vs. FDA/EMA DI guidelines and best practices
  • Development of upgrade and remediation strategies
  • Current-State DI Maturity Scorecard
  • Gap Analysis & Risk Matrix
  • Prioritized Remediation Plan
  • Updated DI SOPs
  • Support for Remediation Execution

Cybersecurity Readiness Audits (GxP Focused)

Identify and mitigate cybersecurity risks in GxP-critical digital systems to protect data integrity, ensure operational continuity, and align with global regulatory expectations.

  • Assessment of GxP digital systems (eQMS, eTMF, LIMS, MES, SCADA)
  • Evaluation of vulnerabilities and data protection measures
  • Cybersecurity Audit Report
  • GxP-Specific Cyber Risk Remediation Plan

QA/AI & ML Compliance Services

Partner with us for expert digital compliance and quality solutions. Contact ProPharma today to learn how we can support your organization’s Artificial Intelligence governance and Quality Assurance needs.

News & Insights

FDA's Shift to One Pivotal Trial for Drug Approval: Regulatory Strategy Implications for Sponsors

February 24, 2026

FDA's Shift to One Pivotal Trial for Drug Approval: Regulatory Strategy Implicat...

FDA’s shift to one pivotal trial raises global stakes. Learn how to engineer globally acceptable development programs from the start.

User Requirements for AI in GxP: Designing, Selecting, and Validating AI/ML Software with Confidence

February 23, 2026

User Requirements for AI in GxP: Designing, Selecting, and Validating AI/ML Soft...

Effective AI/ML implementation in life sciences requires clear user requirements, robust validation, and strong governance to ensure compliance and performance.

Why Medical Information Is Central to MAH Compliance, Access, and Patient Safety – Identifying Reportable Information

February 19, 2026

Why Medical Information Is Central to MAH Compliance, Access, and Patient Safety...

Learn why Medical Information is essential for MAH compliance, patient safety, and capturing reportable data, ensuring trust and proactive insights in real-world medical use.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

December 4, 2025

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

ProPharma taps Daniel Ryan as President of Clinical Research Solutions, strengthening its clinical trial management leadership and expanding its FSP Solutions.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Setting up a Global PV System - ProPharma

February 5, 2026

Setting up a Global PV System

A company needed to rapidly establish a fully compliant global pharmacovigilance (PV) system, including UK/EU QPPV coverage, to meet regulatory requirements by a fixed deadline. With safety data and...

Case Study High-Volume Global Pharmacovigilance Onboarding - ProPharma

January 30, 2026

High-Volume Global Pharmacovigilance Onboarding

A global biotechnology sponsor faced a sudden surge in pharmacovigilance demand, with monthly ICSR volumes exceeding 30,000 cases across multiple regions. Limited internal capacity, tight onboarding...

Case Study Stabilizing High-Volume Legal Case Processing Through Structured Governance - ProPharma

January 28, 2026

Stabilizing High-Volume Legal Case Processing Through Structured Governance

ProPharma’s client faced escalating operational risk as high-volume legal case documentation overwhelmed their prior vendor. Thousands of documents, missed regulatory timelines, and a surge of...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs

March 12, 2026

Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs

Uncover the intricacies of Pharmacovigilance System Master File (PSMF) management and explore proven strategies to ensure inspection readiness, effective MAH oversight, and regulatory compliance...

News & Insights

FDA's Shift to One Pivotal Trial for Drug Approval: Regulatory Strategy Implications for Sponsors

February 24, 2026

FDA's Shift to One Pivotal Trial for Drug Approval: Regulatory Strategy Implicat...

FDA’s shift to one pivotal trial raises global stakes. Learn how to engineer globally acceptable development programs from the start.

User Requirements for AI in GxP: Designing, Selecting, and Validating AI/ML Software with Confidence

February 23, 2026

User Requirements for AI in GxP: Designing, Selecting, and Validating AI/ML Soft...

Effective AI/ML implementation in life sciences requires clear user requirements, robust validation, and strong governance to ensure compliance and performance.

Why Medical Information Is Central to MAH Compliance, Access, and Patient Safety – Identifying Reportable Information

February 19, 2026

Why Medical Information Is Central to MAH Compliance, Access, and Patient Safety...

Learn why Medical Information is essential for MAH compliance, patient safety, and capturing reportable data, ensuring trust and proactive insights in real-world medical use.

Previous Post Arrow Next Post Arrow
ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

December 4, 2025

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

ProPharma taps Daniel Ryan as President of Clinical Research Solutions, strengthening its clinical trial management leadership and expanding its FSP Solutions.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Setting up a Global PV System - ProPharma

February 5, 2026

Setting up a Global PV System

A company needed to rapidly establish a fully compliant global pharmacovigilance (PV) system, including UK/EU QPPV coverage, to meet regulatory requirements by a fixed deadline. With safety data and...

Case Study High-Volume Global Pharmacovigilance Onboarding - ProPharma

January 30, 2026

High-Volume Global Pharmacovigilance Onboarding

A global biotechnology sponsor faced a sudden surge in pharmacovigilance demand, with monthly ICSR volumes exceeding 30,000 cases across multiple regions. Limited internal capacity, tight onboarding...

Case Study Stabilizing High-Volume Legal Case Processing Through Structured Governance - ProPharma

January 28, 2026

Stabilizing High-Volume Legal Case Processing Through Structured Governance

ProPharma’s client faced escalating operational risk as high-volume legal case documentation overwhelmed their prior vendor. Thousands of documents, missed regulatory timelines, and a surge of...

Previous Resource Arrow Next Resource Arrow
Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs

March 12, 2026

Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs

Uncover the intricacies of Pharmacovigilance System Master File (PSMF) management and explore proven strategies to ensure inspection readiness, effective MAH oversight, and regulatory compliance...

Previous Webinar Arrow Next Webinar Arrow